• 전자통신동향분석
• /
• 제36권1호
• /
• pp.81-88
• /
• 2021

Post COVID-19, the medical legacy system will be transformed for utilizing medical resources efficiently, minimizing medical service imbalance, activating remote medical care, and strengthening private-public medical cooperation. This can be realized by achieving an entire medical paradigm shift and not simply via the application of advanced technologies such as AI. We propose a medical system configuration named "Medical AI Hub" that can realize the shift of the existing paradigm. The development stage of this configuration is categorized into "AI Cooperation Hospital," "AI Base Hospital," and "AI Hub Hospital." In the "AI Hub Hospital" stage, the medical intelligence in charge of individual patients cooperates and communicates autonomously with various medical intelligences, thereby achieving synchronous evolution. Thus, this medical intelligence supports doctors in optimally treating patients. The core technologies required during configuration development and their current R&D trends are described in this paper. The realization of the central configuration of medical AI through the development of these core technologies will induce a paradigm shift in the new medical system by innovating all medical fields with influences at the individual, society, industry, and public levels and by making the existing medical system more efficient and intelligent.

• International Journal of Advanced Culture Technology
• /
• 제11권1호
• /
• pp.283-289
• /
• 2023

AI is bringing about drastic changes not only in the aspect of technologies but also in society and culture. Medical AI based on deep learning have developed rapidly. Especially, the field of medical image analysis has been proven that AI can identify the characteristics of medical images more accurately and quickly than clinicians. Evaluating the latest results of the AI-based medical image processing is important for the implication for the development direction of medical AI. In this paper, we analyze and evaluate the latest trends in AI-based medical image analysis, which is showing great achievements in the field of medical AI in the healthcare industry. We analyze deep learning models for medical image analysis and AI-based medical image segmentation for quantitative analysis. Also, we evaluate the future development direction in terms of marketability as well as the size and characteristics of the medical AI market and the restrictions to market growth. For evaluating the latest trend in the deep learning-based medical image processing, we analyze the latest research results on the deep learning-based medical image processing and data of medical AI market. The analyzed trends provide the overall views and implication for the developing deep learning in the medical fields.

• International Journal of Computer Science & Network Security
• /
• 제24권1호
• /
• pp.9-16
• /
• 2024

AI or Artificial Intelligence has been a significant tool used in the organisational backgrounds for an effective improvement in the management methods. The processing of the information and the analysis of the data for the further achievement of heightened efficiency can be performed by AI through its data analytics measures. In the medical field, AI has been integrated for an improvement within the management of the medical services and to note a rise in the levels of customer satisfaction. With the benefits of reasoning and problem solving, AI has been able to initiate a range of benefits for both the consumers and the medical personnel. The main benefits which have been noted in the integration of AI would be integrated into the study. The issues which are noted with the integrated AI usage for the medical sector would also be identified in the study. Medical Image Processing has been seen to integrate 3D image datasets with the medical industry, in terms of Computed Tomography (CT) or Magnetic Resonance Imaging (MRI). The usage of such medical devices have occurred in the diagnosis of the patients, the development of guidance towards medical intervention and an overall increase in the medical efficiency. The study would focus on such different tools, adhered with AI for increased medical improvement.

• 한국컴퓨터정보학회논문지
• /
• 제25권9호
• /
• pp.173-182
• /
• 2020

본 논문의 목적은 "인공지능(AI)+의료미용" 이라는 새로운 서비스 수단이 고객의 구매 의도에 미치는 영향하는 것이다. AI 의료뷰티 APP 마케팅 방식을 실증 연구로 한다. 본 논문은 SPSS 24.0 와 AMOS24.0 구조방정식 통계 소프트웨어를 이용하여 통계분석을 실시하였다. 분석방법은 신뢰성분석, 타당성분석, 구조방정식모형분석 등을 이용하였다. 실증연구를 통해 다음과 같은 결과를 얻었다. 1. AI의료용 뷰티 APP의 시스템품질은 유용성과 사용편의성에 긍정적인 영향을 미친다. 2. AI의료APP는 유용성과 사용 편의성에 긍정적인 영향을 미친다. 3. AI의료용 뷰티 APP는 인식된 유용성과 인식된 사용편의성에 긍정적인 영향을 미친다. 4. 소비자가 인식된 사용 편의성은 인식된 유용성과 구매 의지에 긍정적인 영향을 미친다. 5. 소비자의 유용성을 알리는 것은 구매 의사에 긍정적인 영향을 미친다.

• Journal of Medicine and Life Science
• /
• 제21권3호
• /
• pp.92-101
• /
• 2024

This study investigated how the use of a conversational artificial intelligence (AI) chatbot improved medical students' patient-centered communication (PCC) skills and how it affected their motivation to learn using innovative interactive tools such as AI chatbots throughout their careers. This study adopted a one-group post-test-only design to investigate the impact of AI chatbot-based learning on medical students' PCC skills, their learning motivation with AI chatbots, and their perception towards the use of AI chatbots in their learning. After a series of classroom activities, including metaverse exploration, AI chatbot-based learning activities, and classroom discussions, 43 medical students completed three surveys that measured their motivation to learn using AI tools for medical education, their perception towards the use of AI chatbots in their learning, and their self-assessment of their PCC skills. Our findings revealed significant correlations among learning motivation, PCC scores, and perception variables. Notably, the perception towards AI chatbot-based learning and AI chatbot learning motivation showed a very strong positive correlation (r=0.72), indicating that motivated students were more likely to perceive chatbots as beneficial educational tools. Additionally, a moderate correlation between motivation and self-assessed PCC skills (r=0.54) indicated that students motivated to use AI chatbots tended to rate their PCC skills more favorably. Similarly, a positive relationship (r=0.68) between students' perceptions of chatbot usage and their self-assessed PCC skills indicated that enhancing students' perceptions of AI tools could lead to better educational outcomes.

• Korean Circulation Journal
• /
• 제53권11호
• /
• pp.758-771
• /
• 2023

Background and Objectives: Paroxysmal atrial fibrillation (AF) is a major potential cause of embolic stroke of undetermined source (ESUS). However, identifying AF remains challenging because it occurs sporadically. Deep learning could be used to identify hidden AF based on the sinus rhythm (SR) electrocardiogram (ECG). We combined known AF risk factors and developed a deep learning algorithm (DLA) for predicting AF to optimize diagnostic performance in ESUS patients. Methods: A DLA was developed to identify AF using SR 12-lead ECG with the database consisting of AF patients and non-AF patients. The accuracy of the DLA was validated in 221 ESUS patients who underwent insertable cardiac monitor (ICM) insertion to identify AF. Results: A total of 44,085 ECGs from 12,666 patient were used for developing the DLA. The internal validation of the DLA revealed 0.862 (95% confidence interval, 0.850-0.873) area under the curve (AUC) in the receiver operating curve analysis. In external validation data from 221 ESUS patients, the diagnostic accuracy of DLA and AUC were 0.811 and 0.827, respectively, and DLA outperformed conventional predictive models, including CHARGE-AF, C2HEST, and HATCH. The combined model, comprising atrial ectopic burden, left atrial diameter and the DLA, showed excellent performance in AF prediction with AUC of 0.906. Conclusions: The DLA accurately identified paroxysmal AF using 12-lead SR ECG in patients with ESUS and outperformed the conventional models. The DLA model along with the traditional AF risk factors could be a useful tool to identify paroxysmal AF in ESUS patients.

• 대한의용생체공학회:의공학회지
• /
• 제44권6호
• /
• pp.428-442
• /
• 2023

In this study, we have a goal to develop usability evaluation guidelines for heuristic-based artificial intelligence-based Software as a Medical Device (SaMD) in the medical field. We conducted a gap analysis between medical hardware (H/W) and non-medical software (S/W) based on ten heuristic principles. Through severity assessments, we identified 69 evaluation domains and 112 evaluation criteria aligned with the ten heuristic principles. Subsequently, we categorized each evaluation domain into five types, including user safety, data integrity, regulatory compliance, patient therapeutic effectiveness, and user convenience. We proposed usability evaluation guidelines that apply the newly derived heuristic-based Software as a Medical Device (SaMD) evaluation factors to the risk management process. In the discussion, we also have proposed the potential applications of the research findings and directions for future research. We have emphasized the importance of the judicious application of AI technology in the medical field and the evaluation of usability evaluation and offered valuable guidelines for various stakeholders, including medical device manufacturers, healthcare professionals, and regulatory authorities.

• 의학교육논단
• /
• 제22권2호
• /
• pp.99-114
• /
• 2020

The rapid development of artificial intelligence (AI), including deep learning, has led to the development of technologies that may assist in the diagnosis and treatment of diseases, prediction of disease risk and prognosis, health index monitoring, drug development, and healthcare management and administration. However, in order for AI technology to improve the quality of medical care, technical problems and the efficacy of algorithms should be evaluated in real clinical environments rather than the environment in which algorithms are developed. Further consideration should be given to whether these models can improve the quality of medical care and clinical outcomes of patients. In addition, the development of regulatory systems to secure the safety of AI medical technology, the ethical and legal issues related to the proliferation of AI technology, and the impacts on the relationship with patients also need to be addressed. Systematic training of healthcare personnel is needed to enable adaption to the rapid changes in the healthcare environment. An overall review and revision of undergraduate medical curriculum is required to enable extraction of significant information from rapidly expanding medical information, data science literacy, empathy/compassion for patients, and communication among various healthcare providers. Specialized postgraduate AI education programs for each medical specialty are needed to develop proper utilization of AI models in clinical practice.

• Korean Journal of Radiology
• /
• 제22권3호
• /
• pp.442-453
• /
• 2021

Artificial intelligence (AI) will likely affect various fields of medicine. This article aims to explain the fundamental principles of clinical validation, device approval, and insurance coverage decisions of AI algorithms for medical diagnosis and prediction. Discrimination accuracy of AI algorithms is often evaluated with the Dice similarity coefficient, sensitivity, specificity, and traditional or free-response receiver operating characteristic curves. Calibration accuracy should also be assessed, especially for algorithms that provide probabilities to users. As current AI algorithms have limited generalizability to real-world practice, clinical validation of AI should put it to proper external testing and assisting roles. External testing could adopt diagnostic case-control or diagnostic cohort designs. A diagnostic case-control study evaluates the technical validity/accuracy of AI while the latter tests the clinical validity/accuracy of AI in samples representing target patients in real-world clinical scenarios. Ultimate clinical validation of AI requires evaluations of its impact on patient outcomes, referred to as clinical utility, and for which randomized clinical trials are ideal. Device approval of AI is typically granted with proof of technical validity/accuracy and thus does not intend to directly indicate if AI is beneficial for patient care or if it improves patient outcomes. Neither can it categorically address the issue of limited generalizability of AI. After achieving device approval, it is up to medical professionals to determine if the approved AI algorithms are beneficial for real-world patient care. Insurance coverage decisions generally require a demonstration of clinical utility that the use of AI has improved patient outcomes.

• KSII Transactions on Internet and Information Systems (TIIS)
• /
• 제16권8호
• /
• pp.2772-2786
• /
• 2022

We had researched an automatic authentication-supported medical information platform[6]. The proposed automatic authentication consists of user authentication and mobile terminal authentication, and the authentications are performed simultaneously in patients' emergency conditions. In this paper, we studied on finding emergency conditions for the automatic authentication by applying big data processing and AI mechanism on the extended medical information platform with an added edge computing system. We used big data processing, SVM, and 1-Dimension CNN of AI mechanism to find emergency conditions as authentication means considering patients' underlying diseases such as hypertension, diabetes mellitus, and arrhythmia. To quickly determine a patient's emergency conditions, we placed edge computing at the end of the platform. The medical information server derives patients' emergency conditions decision values using big data processing and AI mechanism and transmits the values to an edge node. If the edge node determines the patient emergency conditions, the edge node notifies the emergency conditions to the medical information server. The medical server transmits an emergency message to the patient's charge medical staff. The medical staff performs the automatic authentication using a mobile terminal. After the automatic authentication is completed, the medical staff can access the patient's upper medical information that was not seen in the normal condition.